GlaxoSmithKline(GSK)
$50.41-0.04 (-0.08%)
GSK
GlaxoSmithKline financials statements
$50.41
At close:-0.04 (-0.08%)
Want to see GSK full AI Analyst Report?
GlaxoSmithKline (GSK) Income Statement
5,274 Followers
GlaxoSmithKline Income Statement
Last quarter (Q3 2026), GlaxoSmithKline's total revenue was £8.82B, an increase of 3.16% from the same quarter last year. In Q3, GlaxoSmithKline's net income was £1.53B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 32.67B | £ 31.38B | £ 30.33B | £ 29.32B | £ 24.70B | |
| £ 23.65B | £ 22.33B | £ 21.76B | £ 19.77B | £ 16.53B | |
| £ 15.72B | £ 18.31B | £ 15.02B | £ 13.34B | £ 12.18B | |
| Depreciation and Amortization | £ 2.31B | £ 2.55B | £ 2.29B | £ 2.15B | £ 2.12B |
| £ 10.37B | £ 6.67B | £ 9.15B | £ 8.56B | £ 6.49B | |
| £ 7.93B | £ 4.02B | £ 6.75B | £ 6.43B | £ 4.36B | |
| £ -531.00M | £ -544.00M | £ -681.00M | £ -805.00M | £ -758.00M | |
| £ 7.40B | £ 3.48B | £ 6.06B | £ 5.63B | £ 3.60B | |
| £ 5.72B | £ 2.58B | £ 4.93B | £ 14.96B | £ 4.38B | |
| Per Share Metrics | |||||
| Basic EPS | £ 2.82 | £ 1.26 | £ 2.43 | £ 7.43 | £ 2.74 |
| Diluted EPS | £ 2.78 | £ 1.24 | £ 2.40 | £ 7.32 | £ 2.70 |
| Weighted Average Shares Outstanding | 2.03B | 2.04B | 2.03B | 2.01B | 1.60B |
| Weighted Average Shares Outstanding (Diluted) | 2.06B | 2.07B | 2.06B | 2.04B | 1.62B |
Currency in GBP

